🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this Phase I clinical trial is to evaluate how the imaging drug...
Status
Recruiting
Location
Excel Diagnostics & Nuclear Oncology Center
Start Date
2026-08-15
Trial ID
NCT07733674
Treatments Being Tested
Neuroendocrine tumours (NETs) are generally slow growing, but some can be a...
Status
Completed
Location
BC Cancer
Start Date
2020-06-09
Trial ID
NCT04207762
Treatments Being Tested
This study will examine the synaptotrophic effects of psilocybin among medi...
Status
Recruiting
Location
Yale University
Start Date
2025-05-28
Trial ID
NCT06160284
Treatments Being Tested
This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Status
Completed
Location
Ep0074 001
Start Date
2015-11
Trial ID
NCT02602860
Treatments Being Tested
NPC Patients receiving IMRT treatment will receive a dedicated FDG PET/CT a...
Status
Unknown
Location
Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center
Start Date
2020-05-20
Trial ID
NCT04394091
Treatments Being Tested
This study is designed to obtain basic information on three PET imaging tra...
Status
Completed
Location
Parexel International; Harbor Hospital Center
Start Date
2014-08-31
Trial ID
NCT02187627
Treatments Being Tested
This is a clinical trial category C as this is a first in man trial with an...
Status
Completed
Location
Lausanne University Hospitals
Start Date
2017-04-01
Trial ID
NCT03242993
Treatments Being Tested
This study correlated changes from baseline in Ki-67, an immunohistochemica...
Status
Completed
Location
Multiple Locations
Start Date
2010-04-08
Trial ID
NCT01015131
Treatments Being Tested
Tourette disorder (TD) is a neurodevelopmental disorder characterized by mo...
Status
Recruiting
Location
Service de neurologie C Hôpital neurologique Pierre Wertheimer/GHE Hospices Civils de Lyon
Start Date
2024-09-24
Trial ID
NCT05942716
Treatments Being Tested